Clinical Trial Update: A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Avastin (bevacizumab) with oxaliplatin and capecitabine (Xeloda) in patients with advanced colorectal cancer has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15